UPLC-Tandem Mass Spectrometry Method for Simultaneous Determination of Fluoxetine, Risperidone, and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Pharmacokinetics Study in Rats
- PMID: 28656122
- PMCID: PMC5471578
- DOI: 10.1155/2017/5187084
UPLC-Tandem Mass Spectrometry Method for Simultaneous Determination of Fluoxetine, Risperidone, and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Pharmacokinetics Study in Rats
Abstract
Risperidone (RIS) is used as an antipsychotic drug alone or with other drugs, like fluoxetine (FLX). A simple method was developed and validated for the determination of both RIS and its metabolite 9-hydroxyrisperidone (9-OH-RIS), FLX, and olanzapine (OLA) as an internal standard in rat's plasma using UPLC-MS/MS. FLX, RIS, 9-OH-RIS, and OLA were purified using acetonitrile as a protein precipitating agent. Separation was performed on an ACQUITY™ "UPLC BEH™" C18 column (50 mm × 2.1 mm i.d., 1.7 μm; Waters Corp., USA). The ranges of the calibration curves were 1.0-1000.0 ng/mL for FLX and 0.2-1000.0 ng/mL for RIS and 9-OH-RIS. Linearity, recovery, precision, and stability were within the acceptable range. This method is rapid, fast, and precise for the determination of RIS and FLX in plasma and is applicable in pharmacokinetic studies.
Figures







Similar articles
-
New Modified UPLC/Tandem Mass Spectrometry Method for Determination of Risperidone and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Dose-Dependent Pharmacokinetic Study in Sprague-Dawley Rats.Int J Anal Chem. 2017;2017:1271383. doi: 10.1155/2017/1271383. Epub 2017 May 3. Int J Anal Chem. 2017. PMID: 28553353 Free PMC article.
-
Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.J Pharm Biomed Anal. 2019 Mar 20;166:244-251. doi: 10.1016/j.jpba.2019.01.023. Epub 2019 Jan 14. J Pharm Biomed Anal. 2019. PMID: 30665192
-
Concurrent determination of olanzapine, risperidone and 9-hydroxyrisperidone in human plasma by ultra performance liquid chromatography with diode array detection method: application to pharmacokinetic study.Biomed Chromatogr. 2016 Feb;30(2):263-8. doi: 10.1002/bmc.3545. Epub 2015 Jul 30. Biomed Chromatogr. 2016. PMID: 26129833
-
A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic.Curr Pharm Biotechnol. 2020;21(1):60-69. doi: 10.2174/1389201020666190830150549. Curr Pharm Biotechnol. 2020. PMID: 31470784
-
Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders.J Clin Lab Anal. 2016 Nov;30(6):1236-1246. doi: 10.1002/jcla.22009. Epub 2016 Jun 26. J Clin Lab Anal. 2016. PMID: 27346210 Free PMC article.
Cited by
-
LC-MS/MS Method for Simultaneous Quantification of Dexmedetomidine, Dezocine, and Midazolam in Rat Plasma and Its Application to Their Pharmacokinetic Study.J Anal Methods Chem. 2018 May 20;2018:3184759. doi: 10.1155/2018/3184759. eCollection 2018. J Anal Methods Chem. 2018. PMID: 29888025 Free PMC article.
References
-
- Soni H. In: Martindale—The Complete Drug Reference. 33rd. Sweetman S. C., editor. London, UK: The Pharmaceutical Press; 2002. - DOI
-
- Wernicke J. F. The side effect profile and safety of fluoxetine. Journal of Clinical Psychiatry. 1985;46(3):59–67. - PubMed
-
- Pooterand W. Z., Hollister L. E. Katzung B. G. Basic & Clinical Pharmacology. 9th. 2004. Antidepressant agents; pp. 482–496.
-
- Meltzer H. Y. Mechanism of action of atypical antipsychotic drugs. In: Davis K. L., Charney Coyle J. T., Nemeroff C., editors. Neuropsy Chopharmacology. Philadelphia, Pa, USA: Lippincott Williams & Wilkins; 2002. pp. 819–831.
LinkOut - more resources
Full Text Sources
Other Literature Sources